ClinTec Appoints Austin Clark as Director Global Clinical Resourcing
News May 04, 2010
ClinTec International announces the extension of its senior management team with the appointment of Austin Clarke, Director of Global Clinical Resourcing. Austin brings over 9 years of experience in management and delivery of large scale resourcing programmes in healthcare and other industries. He gained a degree in Marketing from the University of Abertay in Dundee, UK before beginning his career within Recruitment Services in 2010.
Austin Clarke joins from global recruitment agency, Adecco, holding various sales and marketing positions in UK-based offices in Scotland, the South West of England and finally through promotion to country manager in Ireland. At ClinTec, Austin will further develop the Global Clinical Resourcing model on an international basis and manage ClinTec’s relationships with pharmaceutical companies at a senior level.
ClinTec International continues to invest in its Global Clinical Resourcing solution through ongoing Partnerships with major pharmaceutical companies. Following 13 years of successful business in Global Clinical Resourcing, in 2009, for one client alone (a major pharmaceutical company), ClinTec delivered 51 personnel (mainly CRAs) located across 17 different countries and sees further expansion in this area in the future.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Anti-Malaria Drugs Delivered With CaffeineNews
Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018